Royal Bank of Canada’s Zosano Pharma Corporation ZSAN Stock Holding History

Royal Bank of Canada’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4	Closed	–	–	8213
2022 Q1	$0	Hold	4	–	–	﹤0.01%	8268
2021 Q4	$0	Sell	4 -7	-64%	-$148	﹤0.01%	8204
2021 Q3	$0	Buy	11 +7	+175%	+$182	﹤0.01%	8094
2021 Q2	$0	Hold	4	–	–	﹤0.01%	7879
2021 Q1	$0	Sell	4 -100	-96%	-$4.19K	﹤0.01%	7843
2020 Q4	$2K	Sell	104 -71	-41%	-$1.39K	﹤0.01%	6899
2020 Q3	$10K	Buy	175 +163	+1,358%	+$7.59K	﹤0.01%	5934
2020 Q2	$0	Hold	12	–	–	﹤0.01%	7069
2020 Q1	$0	Sell	12 -214	-95%	-$7.17K	﹤0.01%	7194
2019 Q4	$12K	Buy	226 +213	+1,638%	+$13.1K	﹤0.01%	6088
2019 Q3	$1K	Buy	+13	New	+$1.17K	﹤0.01%	6582
2018 Q1	–	Hold	0	–	–	–	6983
2017 Q4	–	Hold	0	–	–	–	7055
2017 Q3	–	Hold	0	–	–	–	7107

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Royal Bank of Canada's ZSAN Position: Q2 2022 in Review

Royal Bank of Canada sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 4 shares.

Royal Bank of Canada first reported a position in ZSAN in Q3 2019 and held it in 11 quarters. The position peaked at $12K in Q4 2019. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Royal Bank of Canada reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Royal Bank of Canada sold 4 Zosano Pharma Corporation shares in Q2 2022.
Royal Bank of Canada first reported a position in Zosano Pharma Corporation in Q3 2019 and held it in 11 quarters.
Royal Bank of Canada's Zosano Pharma Corporation position peaked at $12K in Q4 2019.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.